SCU-19812-90282
2 vaccinations
1 coded response
12 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 946 / CA
- Registered
- 2022-06-21
- Relationship
- Child or adolescent in my care
- Guardian
- WRX-11846-55110
- Race
- Multiracial
- Ethnicity
- Hispanic or Latino
Timeline
-
2022-06-21
Registered in v-safe
-
2022-06-21
Dose 1 — Moderna
- 2022-06-27
- 2022-06-28
- 2022-07-11
-
2022-07-12
Survey response — day 21, dose 1, under 3MedDRA: Cough, Nasopharyngitis, Pyrexia, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend schoolFree text: Common cold symptoms (low grade fever, runny nose, asthma related cough), Covid negativeMedDRA releases: 2024-11 · check-in free text available
-
2022-07-19
Dose 2 — Moderna
- 2022-07-20
- 2022-07-21
- 2022-07-22
- 2022-07-23
- 2022-07-24
- 2022-07-25
- 2022-07-26
- 2023-01-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-21 | Moderna | No |
| 2 | 2022-07-19 | Moderna | No |
Free text
Release 12 (Under 3) — day 21, dose 1, under 3
Symptoms: Common cold symptoms (low grade fever, runny nose, asthma related cough), Covid negative
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Cough variant asthma | · | · | ○ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release